Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life

Sponsor
CHU de Quebec-Universite Laval (Other)
Overall Status
Unknown status
CT.gov ID
NCT01141933
Collaborator
Laval University (Other), Centre de recherche en cancérologie de l'Université Laval (Other), Canadian Cancer Society (CCS) (Other), Maison Michel-Sarrazin (Other)
513
6
3
113.9
85.5
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to test the efficacy of a cognitive-existential intervention (using either an individual or a group format) to improve the existential and global quality of life of patients as compared to usual care in a population of adult non-metastatic cancer patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Cognitive-existential intervention
  • Other: Usual care
N/A

Detailed Description

People diagnosed with cancer must learn to cope with loss of meaning and empowerment which compromises quality of life. Questions regarding "Why me?", along with universal existential concerns about death, search for meaning, and sense of control over one's life, often constitute the principal source of overall suffering. Since there is no single and identifiable cause for cancer, those existential questions are commonly observed among patients who demand specific interventions to properly address this central issue. The existential approach can be used to help patients find meaning in the midst of a crisis. It addresses a central issue of survivorship in cancer.

The conceptual model explains the relation between being exposed to a stressful and traumatic life event such as cancer and the risk of progressing toward adjustment difficulties which compromises quality of life and existential integrity. Cancer constitutes a major stressor involving significant losses that confronts the person's beliefs system. A set of therapeutic strategies can help to cope with this inevitable challenge: 1) cognitive-behavioral strategies; 2) direct existential intervention; and 3) social support through supportive-expressive strategies. Adjustment first involves cognitive reframing of the perception of the situation (situational meaning). Cognitive reframing also contributes to a readjustment of personal beliefs and values (global meaning and existential dimension). Existential strategies enable to further this process by including cognitive (beliefs, sense of coherence, expectations), motivational (choice, goal setting, and goal driving) and affective dimensions. The expressive-supportive strategy promotes active listening and non-judgmental support to encourage expression of emotions. The use of these active coping strategies (meaning-based) to the threatened-life challenge enables optimization of existential and global quality of life, as opposed to employing passive strategies such as avoidance.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
513 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Creating Meaning Following Cancer: An Cognitive-existential Intervention to Improve Existential and Global Quality of Life
Study Start Date :
Feb 1, 2009
Actual Primary Completion Date :
Dec 1, 2013
Anticipated Study Completion Date :
Aug 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Usual care

Subjects in this group receive the usual treatment only.

Other: Usual care
This group receive the usual treatment only.

Experimental: Individual intervention

Consisting in a 12 weekly sessions with a therapist. Each session lasts 1 hour.

Other: Cognitive-existential intervention
Over the past 2 years we developed a 12-week cognitive-existential intervention consisting of 12 modules. The first three modules essentially involve cognitive and behavioral techniques proposing reinforcement of the use of active behavioral (e.g., relaxation, activation) and emotional (cognitive reframing) strategies. This content comes from classical cognitive-behavioral techniques. The next 3 modules, inspired by empirically-tested interventions further explore emotional strategies. The last six modules specifically address the existential dimension. They are adapted from logotherapy techniques, which are also empirically-based, and have been adapted to a French-Canadian culture by our team. They aim to improve meaning-based and emotional coping strategies.

Experimental: Group intervention

Consisting in a 12 weekly sessions with two therapists. Number of subjects in each group is from 5 to 10. Each session lasts 2 hours.

Other: Cognitive-existential intervention
Over the past 2 years we developed a 12-week cognitive-existential intervention consisting of 12 modules. The first three modules essentially involve cognitive and behavioral techniques proposing reinforcement of the use of active behavioral (e.g., relaxation, activation) and emotional (cognitive reframing) strategies. This content comes from classical cognitive-behavioral techniques. The next 3 modules, inspired by empirically-tested interventions further explore emotional strategies. The last six modules specifically address the existential dimension. They are adapted from logotherapy techniques, which are also empirically-based, and have been adapted to a French-Canadian culture by our team. They aim to improve meaning-based and emotional coping strategies.

Outcome Measures

Primary Outcome Measures

  1. Existential quality of life [T0: Pre-intervention]

    At every time frame, we use two questionnaires to measure the primary outcome: The McGill Quality of Life Questionnaire (MQOL): 16 items plus a single-item global scale. Spiritual well-being (FACIT-SP): The FACIT-SP is a sub-scale of the FACT-G (Functional Assessment of Cancer Therapy-General) and a French version of the "FACIT-SP, FACIT-Spiritual well-being scale". This questionnaire has two sub-scales: Meaning/Peace (8 items) and Faith (4 items).

  2. Existential quality of life [T1: Mid-intervention (6 weeks after the beginning of the intervention)]

  3. Existential quality of life [T2: End of the intervention (12 weeks after the beginning of the intervention)]

  4. Existential quality of life [T3: First follow-up measure (3 months after the end of the intervention)]

  5. Existential quality of life [T4: Second follow-up measure (6 months after the end of the intervention)]

  6. Existential quality of life [T5: Last follow-up measure (12 months after the end of the intervention)]

Secondary Outcome Measures

  1. Global quality of life [T0: Pre-intervention]

    To measure the secondary outcome, The McGill Quality of Life Questionnaire (MQOL) is use at every time frames.

  2. Global quality of life [T1: Mid-intervention (6 weeks after the beginning of the intervention)]

  3. Global quality of life [T2: End of the intervention (12 weeks after the beginning of the intervention)]

  4. Global quality of life [T3: First follow-up measure (3 months after the end of the intervention)]

  5. Global quality of life [T4: Second follow-up measure (6 months after the end of the intervention)]

  6. Global quality of life [T5: Last follow-up measure (12 months after the end of the intervention)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be of 18 years of age or more;

  • Speak French;

  • Have received a diagnosis of non-metastatic cancer;

  • Be available to participate in the program of 12 weekly group or individual sessions.

Exclusion Criteria:
  • Depressive mood (score greater than 10 on the Hospital Anxiety and Depression Scale depressive subscale) that could interfere with the intervention. Since we specifically target the existential dimension and it might temporarily provoke questioning in patients, high psychological distress must first be addressed using other approaches.

  • Diagnosis of metastatic cancer or diagnosis of non-metastatic cancer with a usually fast-growing and unpredictable course, making it unlikely to adhere to the intervention (e.g., pancreatic cancer, acute leukemia, glioblastoma).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Manitoba Winnipeg Manitoba Canada R3T 2N2
2 Centre hospitalier affilié universitaire de l'Hôtel-Dieu de Lévis Lévis Quebec Canada G6V 3Z1
3 McGill University Montreal Quebec Canada H3A 2T5
4 CHU de Québec - Université Laval Quebec Canada G1R2J6
5 CHU de Québec - Université Laval Québec Canada G1S 4L8
6 Institut universitaire de cardiologie et de pneumologie de Québec Québec Canada G1V 4G5

Sponsors and Collaborators

  • CHU de Quebec-Universite Laval
  • Laval University
  • Centre de recherche en cancérologie de l'Université Laval
  • Canadian Cancer Society (CCS)
  • Maison Michel-Sarrazin

Investigators

  • Principal Investigator: Pierre Gagnon, MD, FRCPC, Laval University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Pierre Gagnon, MD, FRCPC, Psychiatrist, CHU de Quebec-Universite Laval
ClinicalTrials.gov Identifier:
NCT01141933
Other Study ID Numbers:
  • CSS-019126
First Posted:
Jun 11, 2010
Last Update Posted:
Mar 6, 2018
Last Verified:
Mar 1, 2018
Keywords provided by Pierre Gagnon, MD, FRCPC, Psychiatrist, CHU de Quebec-Universite Laval
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2018